Bartlett & Co’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$714K Hold
11,100
0.01% 312
2023
Q3
$504K Hold
11,100
0.01% 336
2023
Q2
$623K Hold
11,100
0.01% 312
2023
Q1
$502K Hold
11,100
0.01% 290
2022
Q4
$451K Hold
11,100
0.01% 304
2022
Q3
$725K Buy
11,100
+6,000
+118% +$392K 0.02% 239
2022
Q2
$310K Sell
5,100
-8,500
-63% -$517K 0.01% 320
2022
Q1
$854K Hold
13,600
0.01% 239
2021
Q4
$1.03M Buy
+13,600
New +$1.03M 0.02% 230